FYERS
Home
/
Stocks
/
Results
/
Source Natural Foods and Herbal Supplements Results

Source Natural Foods and Herbal Supplements Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
21%27%28%65%
34%12%6%67%
--6%6%-28%
15%16%12%14%

Peer Comparison

Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
ZYDUSLIFE-A
CIPLA-A
LAURUSLABS-A
LUPIN-A
MANKIND-A
DRREDDY-A
AUROPHARMA-A
SOURCENTRL-X
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,901.5₹456833 Cr37.7712.0762.82₹11479 Cr
9,183.45₹245426 Cr83.9134.04128.41₹2568 Cr
4,855₹187320 Cr85.8916.7297.06₹2163 Cr
1,132.55₹113217 Cr25.099.4262.53₹5040 Cr
1,382.6₹112212 Cr33.299.7757.87₹3879 Cr
1,852.25₹101155 Cr92.526.829.25₹889 Cr
2,124₹97626 Cr17.6630.95154.36₹5333 Cr
2,337₹96859 Cr47.4213.7571.08₹1913 Cr
1,162₹96406 Cr29.925.3263.99₹4196 Cr
1,658.05₹93614 Cr25.2217.9596.84₹3505 Cr
106.25₹69 Cr19.641.146.56₹3 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Jun 2025
₹21 Cr₹12 Cr
₹18 L₹1 L
₹22 Cr₹12 Cr
₹20 Cr₹11 Cr
₹1 Cr₹1 Cr
₹28 L₹16 L
₹92 L₹85 L
₹68 L₹63 L

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Long-Term Borrowings
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
———————————————————
₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹8 Cr₹8 Cr₹8 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹43 L₹2 Cr₹0₹0₹0₹0₹0₹0₹0
₹16 Cr₹13 Cr₹11 Cr₹9 Cr₹7 Cr₹3 Cr₹2 Cr₹1 Cr₹53 L-₹88 L-₹1 Cr-₹2 Cr-₹2 Cr-₹2 Cr-₹2 Cr-₹50 L-₹8 Cr-₹8 Cr-₹7 Cr
₹16 Cr₹13 Cr₹11 Cr₹9 Cr₹7 Cr₹3 Cr₹2 Cr₹1 Cr₹53 L-₹88 L-₹1 Cr-₹2 Cr-₹2 Cr-₹2 Cr-₹2 Cr-₹50 L-₹8 Cr-₹8 Cr-₹7 Cr
₹22 Cr₹19 Cr₹18 Cr₹16 Cr₹13 Cr₹10 Cr₹9 Cr₹8 Cr₹7 Cr₹6 Cr₹5 Cr₹5 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹65 L₹74 L₹84 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹1 Cr₹0₹0₹0₹0
₹0₹0₹0₹0₹0₹10 L₹10 L₹18 L₹30 L₹6 L₹7 L₹0₹0₹0₹0₹0₹0₹0₹30 L
₹0₹0₹35,000₹2 L₹3 L₹0₹0₹0₹0₹0₹0₹0₹2 Cr₹2 Cr₹1 Cr₹47 L₹3 Cr₹2 Cr₹1 Cr
₹9 L₹9 L-₹24 L-₹54 L-₹2 Cr-₹85 L-₹63 L-₹42 L-₹28 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹48 L₹48 L₹55 L₹49 L₹35 L₹34 L₹25 L₹14 L₹10 L₹10 L₹7 L₹4 L₹4 L₹2 L₹1 L₹0₹0₹0₹0
₹57 L₹57 L₹31 L-₹3 L-₹1 Cr-₹41 L-₹27 L-₹11 L₹11 L₹15 L₹14 L₹4 L₹2 Cr₹2 Cr₹1 Cr₹47 L₹3 Cr₹2 Cr₹2 Cr
———————————————————
₹3 Cr₹3 Cr₹2 Cr₹1 Cr₹60 L₹78 L₹60 L₹39 L₹1 Cr₹77 L₹62 L₹31 L₹27 L₹26 L₹28 L₹2 L₹2 L₹1 Cr₹1 Cr
₹9 Cr₹1 Cr₹90 L₹99 L₹1 Cr₹79 L₹75 L₹86 L₹1 Cr₹11 L₹9 L₹10 L₹3 L₹10 L₹2 L₹24 L₹9 L₹0₹0
₹0₹0₹0₹0₹91 L₹1 Cr₹6 L₹2 Cr₹2 Cr₹2 L₹2 L₹0₹0₹0₹0₹0₹0₹0₹0
₹88 L₹81 L₹40 L₹73 L₹91 L₹32 L₹23 L₹17 L₹29 L₹0₹0₹0₹0₹0₹0₹8 L₹3 L₹0₹0
₹13 Cr₹5 Cr₹3 Cr₹3 Cr₹4 Cr₹3 Cr₹2 Cr₹3 Cr₹4 Cr₹90 L₹73 L₹41 L₹30 L₹37 L₹30 L₹35 L₹14 L₹1 Cr₹1 Cr
₹36 Cr₹25 Cr₹21 Cr₹19 Cr₹16 Cr₹12 Cr₹10 Cr₹11 Cr₹11 Cr₹7 Cr₹6 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹20 L₹20 L₹26 L
₹7 Cr₹1 Cr₹2 L₹4 L₹93 L₹1 Cr₹16 L₹2 Cr₹2 Cr₹8 L₹9 L₹0₹2 Cr₹2 Cr₹1 Cr₹47 L₹3 Cr₹2 Cr₹2 Cr
———————————————————
₹11 Cr₹11 Cr₹12 Cr₹10 Cr₹8 Cr₹8 Cr₹7 Cr₹7 Cr₹7 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr
₹7 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹94 L₹86 L₹98 L
₹5 Cr₹6 Cr₹7 Cr₹5 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr
₹0₹0₹0₹0₹34 L₹0₹0₹0₹0₹0₹0₹0₹87,210₹0₹0₹15 L₹17 L₹2 L₹52 L
₹5 Cr₹7 L₹7 L₹7 L₹43 L₹25 L₹23 L₹35 L₹8 L₹3 L₹3 L₹2 L₹2 L₹7 L₹2 L₹0₹0₹0₹0
₹10 Cr₹6 Cr₹7 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr
———————————————————
₹6 Cr₹4 Cr₹4 Cr₹3 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹49 L₹38 L₹33 L₹16 L₹7 L₹0₹0₹2 L
₹12 Cr₹8 Cr₹7 Cr₹8 Cr₹6 Cr₹7 Cr₹3 Cr₹4 Cr₹4 Cr₹83 L₹23 L₹35 L₹12 L₹2 L₹11 L₹33 L₹27 L₹36 L₹75 L
₹7 Cr₹7 Cr₹3 Cr₹87 L₹3 Cr₹1 L₹76 L₹2 L₹20 L₹78 L₹55 L₹47 L₹67 L₹28 L₹7 L₹1 Cr₹5 L₹7 L₹5 L
₹0₹0₹0₹0₹0₹26 L₹18 L₹34 L₹84 L₹2 L₹1 L₹1 L₹5 L₹9 L₹7 L₹67,690₹0₹0₹0
₹86 L₹40 L₹69 L₹2 Cr₹64 L₹43 L₹12 L₹8 L₹52 L₹28 L₹28 L₹28 L₹23 L₹21 L₹19 L₹34 L₹29 L₹26 L₹44 L
₹26 Cr₹19 Cr₹15 Cr₹14 Cr₹11 Cr₹9 Cr₹6 Cr₹7 Cr₹8 Cr₹3 Cr₹2 Cr₹2 Cr₹1 Cr₹95 L₹60 L₹2 Cr₹61 L₹70 L₹1 Cr
₹13 Cr₹14 Cr₹11 Cr₹10 Cr₹7 Cr₹6 Cr₹5 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹58 L₹30 L₹1 Cr₹47 L-₹43 L₹18 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹4 L₹7 L₹15 L₹0₹0₹0
₹36 Cr₹25 Cr₹21 Cr₹19 Cr₹16 Cr₹12 Cr₹10 Cr₹11 Cr₹11 Cr₹7 Cr₹6 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr
₹35₹30₹28₹24₹20₹15₹14₹12₹11₹9₹8₹7₹5₹4₹6₹9₹1₹1₹1
₹35₹30₹28₹24₹20₹15₹14₹12₹11₹9₹8₹7₹5₹4₹6₹9₹1₹1₹1

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
₹4 Cr₹3 Cr₹3 Cr₹4 Cr₹4 Cr₹2 Cr₹1 Cr₹83 L₹1 Cr₹43 L₹16 L₹17 L₹35 L-₹65 L-₹1 Cr-₹73 L-₹9 L-₹10 L-₹2 Cr
₹96 L₹12 L-₹4 L-₹68 L-₹17 L₹29 L₹47 L₹53 L₹41 L₹49 L₹55 L₹25 L₹26 L₹37 L₹65 L₹20 L₹9 L₹18 L₹69 L
-₹4 Cr-₹60 L-₹19 L-₹2 Cr₹59 L-₹3 Cr₹1 Cr-₹1 Cr-₹3 Cr-₹54 L-₹33 L-₹23 L-₹12 L-₹11 L-₹14 L₹6 L-₹90 L₹46 L₹2 Cr
₹7 L₹3 Cr₹3 Cr₹93 L₹4 Cr-₹36 L₹3 Cr₹11 L-₹69 L₹38 L₹38 L₹19 L₹49 L-₹40 L-₹79 L-₹47 L-₹90 L₹54 L₹57 L
₹7 L₹3 Cr₹3 Cr-₹70 L₹4 Cr-₹36 L₹3 Cr₹11 L-₹69 L₹38 L₹38 L₹19 L₹49 L-₹40 L-₹79 L-₹65 L-₹90 L₹54 L₹57 L
-₹5 Cr₹29 L₹6 L₹7 L-₹2 Cr-₹71 L-₹31 L₹14 L-₹2 Cr-₹16 L-₹40 L-₹64 L-₹30 L-₹41 L₹22 L-₹1 Cr-₹18 L-₹75 L-₹36 L
₹5 Cr₹1 Cr-₹53 L-₹1 Cr₹28 L₹32 L-₹2 Cr-₹42 L₹2 Cr₹1 L₹11 L₹25 L₹19 L₹1 Cr₹53 L₹2 Cr₹1 Cr₹24 L-₹43 L
₹13 L₹4 Cr₹2 Cr-₹2 Cr₹3 Cr-₹74 L₹74 L-₹18 L-₹58 L₹23 L₹8 L-₹20 L₹39 L₹21 L-₹4 L₹6 L-₹2 L₹2 L-₹23 L
₹7 Cr₹3 Cr₹87 L₹3 Cr₹1 L₹76 L₹2 L₹20 L₹78 L₹55 L₹47 L₹67 L₹28 L₹7 L₹11 L₹5 L₹7 L₹5 L₹28 L
₹7 Cr₹7 Cr₹3 Cr₹87 L₹3 Cr₹1 L₹76 L₹2 L₹20 L₹78 L₹55 L₹47 L₹67 L₹28 L₹7 L₹11 L₹5 L₹7 L₹5 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)105.00
Volume (₹)11,060.00
High (₹)109.75
Upper Circuit128.45
Low (₹)105.00
Lower Circuit85.65
Prev Close107.05
52W High (₹)170.00
Price106.25
52W Low (₹)96.55

Share Market Cap & Key Ratios Overview

M.Cap (₹)68.91 Cr
Div. Yield (%)0.00
PE Ratio19.64
Debt to Equity0.33
Price to Book5.99
Book Value34.73
EPS (TTM)5.45
Face Value10.00
ROE (%)13.89

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
SOURCENTRL-XNSE
LTP
1W Low
1W High
Market cap (₹)
1901.5-18.6 (-0.97%)
1900.10
1964.85
4,56,833Cr
9183.45-85.55 (-0.92%)
9051.85
9296
2,45,426Cr
4855-180 (-3.57%)
4855
5049
1,87,320Cr
1132.55-54.45 (-4.59%)
1126
1191.45
1,13,217Cr
1382.6-35.4 (-2.50%)
1377
1426.20
1,12,212Cr
1852.25-83.05 (-4.29%)
1812
1947.90
1,01,155Cr
2124-51 (-2.34%)
2117.80
2209
97,626Cr
2337-50.4 (-2.11%)
2323.15
2407.40
96,859Cr
1162-15.8 (-1.34%)
1155
1179.90
96,406Cr
1658.05+8.05 (0.49%)
1623.05
1706.70
93,614Cr
106.25-0.65 (-0.61%)
101.40
115.60
69Cr

Source Natural Foods and Herbal Supplements Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹1.3Cr; with other income of ₹18.4Lakh, profit before interest and tax came to ₹1.2Cr. Interest expense was ₹27.8Lakh; PBT before exceptional items stood at ₹92.2Lakh. Cost mix (full year): raw materials ₹34.56Cr; employee cost ₹3.27Cr; depreciation ₹9.8Lakh; other expenses ₹20.23Cr. Basis: consolidated annual results.

Source Natural Foods and Herbal Supplements Ltd Quaterly Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹1.3Cr; with other income of ₹18.4Lakh, profit before interest and tax came to ₹1.2Cr. Interest expense was ₹27.8Lakh, taking profit before tax to ₹92.2Lakh.